Passa al contenuto
Merck
  • Titanium coated with functionalized carbon nanotubes--a promising novel material for biomedical application as an implantable orthopaedic electronic device.

Titanium coated with functionalized carbon nanotubes--a promising novel material for biomedical application as an implantable orthopaedic electronic device.

Materials science & engineering. C, Materials for biological applications (2014-12-11)
Agata Przekora, Aleksandra Benko, Marek Nocun, Jan Wyrwa, Marta Blazewicz, Grazyna Ginalska
ABSTRACT

The aim of the study was to fabricate titanium (Ti) material coated with functionalized carbon nanotubes (f-CNTs) that would have potential medical application in orthopaedics as an implantable electronic device. The novel biomedical material (Ti-CNTs-H2O) would possess specific set of properties, such as: electrical conductivity, non-toxicity, and ability to inhibit connective tissue cell growth and proliferation protecting the Ti-CNTs-H2O surface against covering by cells. The novel material was obtained via an electrophoretic deposition of CNTs-H2O on the Ti surface. Then, physicochemical, electrical, and biological properties were evaluated. Electrical property evaluation revealed that a Ti-CNTs-H2O material is highly conductive and X-ray photoelectron spectroscopy analysis demonstrated that there are mainly COOH groups on the Ti-CNTs-H2O surface that are found to inhibit cell growth. Biological properties were assessed using normal human foetal osteoblast cell line (hFOB 1.19). Conducted cytotoxicity tests and live/dead fluorescent staining demonstrated that Ti-CNTs-H2O does not exert toxic effect on hFOB cells. Moreover, fluorescence laser scanning microscope observation demonstrated that Ti-CNTs-H2O surface retards to a great extent cell proliferation. The study resulted in successful fabrication of highly conductive, non-toxic Ti-CNTs-H2O material that possesses ability to inhibit osteoblast proliferation and thus has a great potential as an orthopaedic implantable electronic device.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Acido solforico, ACS reagent, 95.0-98.0%
Sigma-Aldrich
Acido nitrico, ACS reagent, 70%
Sigma-Aldrich
Acido nitrico, 70%, purified by redistillation, ≥99.999% trace metals basis
Sigma-Aldrich
Sodio dodecil solfato, ≥99.0% (GC), dust-free pellets
Sigma-Aldrich
Acido solforico, 99.999%
Sigma-Aldrich
Sodio dodecil solfato, BioUltra, for molecular biology, 10% in H2O
Sigma-Aldrich
Acido nitrico, puriss. p.a., 65.0-67.0%
Sigma-Aldrich
Streptomicina, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Sodio dodecil solfato, BioUltra, for molecular biology, 20% in H2O
Sigma-Aldrich
Sodio dodecil solfato, BioUltra, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
Sodio dodecil solfato, ACS reagent, ≥99.0%
Supelco
Sodio dodecil solfato, dust-free pellets, suitable for electrophoresis, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
Sodio dodecil solfato, ≥98.0% (GC)
Sigma-Aldrich
Sodio dodecil solfato, ReagentPlus®, ≥98.5% (GC)
Supelco
Acido solforico, 0.1 M H2SO4 in water (0.2N), eluent concentrate for IC
Sigma-Aldrich
Streptomicina, powder, BioXtra, suitable for mouse embryo cell culture
Sigma-Aldrich
Streptomicina, powder
Sigma-Aldrich
Phenol Red, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Sodio dodecil solfato, 92.5-100.5% based on total alkyl sulfate content basis
Supelco
Acido nitrico, 0.1 M HNO3 in water (0.1N), eluent concentrate for IC
Sigma-Aldrich
Sodio dodecil solfato, tested according to NF, mixture of sodium alkyl sulfates consisting mainly of sodium dodecyl sulfate
Sigma-Aldrich
Acido nitrico, ACS reagent, ≥90.0%
Supelco
Acido solforico, for the determination of nitrogen, ≥97.0%
Sigma-Aldrich
Phenol Red, ACS reagent
Sigma-Aldrich
Sodio dodecil solfato, BioXtra, ≥99.0% (GC)
Sigma-Aldrich
Streptomycin Ready Made Solution, 100 mg/mL in water
Supelco
Sodio dodecil solfato, suitable for ion pair chromatography, LiChropur, ≥99.0%
Sigma-Aldrich
Sodio dodecil solfato, ≥90% ((Assay))
Sigma-Aldrich
Acido solforico, puriss., meets analytical specification of Ph. Eur., BP, 95-97%
Sodio dodecil solfato, European Pharmacopoeia (EP) Reference Standard